Market insights:
India is the second largest producer and third largest exporter of tobacco in the world. The tobacco industry provides employment to ~46 Mn people. With the evolving facilities provided by the Tobacco Board of India, the market has recorded a total (manufactured and unmanufactured tobacco) export of INR 60.84 Bn in FY 2018.
Segment-wise market insights:
In India, tobacco is harvested mainly in two forms—cigarette tobacco and non-cigarette tobacco. During 2017-2018, non-cigarette tobacco alone had a ~69% market share. Manufacture of cigarette tobacco has significantly reduced, globally, leading to an increase in the sale of non-cigarette tobacco.
Based on consumption, khaini constituted ~11%, and beedi and cigarette had a market share of ~8%. Usage of smoking mediums like hookah, hookli, chhutta, dhumti and chillum, along with edible tobacco like mawa, snuff, gutka, and pan masala have led to the growth of this market.
Considering the consumption-tax revenue ratio of the overall segment of smoked tobacco, legal cigarettes account for ~10% of consumption and ~86% of tax revenues. This implies that even though smokeless tobacco has the highest rate of consumption, more revenue is earned from legal cigarettes. Tobacco, despite it triggering addiction and intoxication, is consumed significantly by Indians, especially in the form of smokeless tobacco.
Among the major cigarette producers in India, ITC Ltd. currently enjoys the highest market share (~84.27%), based on sale. Rest of the share is distributed among minor companies like Kothari Products Ltd., Godfrey Phillips India Ltd., VST Industries Ltd., and others.
Market drivers:
• Over the years, tobacco has become an essential part of the Indian socio-cultural environment, especially in the eastern, northern, and north-eastern parts of the country. A relatively higher income growth compensates for the increasing price of cigarettes, leading to greater consumption. Moreover, societal influences such as peer pressure also aids in driving the demand for tobacco products. These are the crucial factors propelling market growth.
• With the assistance of the Tobacco Board, Indian tobacco producers are using technologically advanced threshing plants and re-drying factories. These facilities are used for increasing the yield of Flue-Cured Virginia (FCV) tobacco, which can then be exported to different countries, across the world. Hence, improved infrastructure drives growth for this market.
Market challenges:
• Cigarette taxes (64% excise duty, 28% GST, and 5% cess) in India are among the highest in the world. Therefore, high tax rates make cigarettes unaffordable to a large section of consumers. As a result, they shift towards the consumption of beedi and other forms of smokeless tobacco. Hence, the overall tobacco market experiences slow growth.
• The Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act of 2003 (COTPA, 2003) imposes a blanket ban on tobacco advertising. This prevents companies from directly advertising their products, because of which they resort to surrogate advertising. Hence, it becomes difficult for manufacturers to promote their brands, limiting the growth of the domestic market.
Companies covered:
1. Ashok and Company Pan Bahar Ltd.
2. Godfrey Phillips India Ltd.
3. Golden Tobacco Company Ltd.
4. ITC Ltd.
5. Kothari Products Ltd.
6. M.R. Tobacco Pvt. Ltd.
7. National Tobacco Company of India Ltd.
8. Pataka Industries Pvt. Ltd.
9. Sinnar Bidi Udyog Ltd.
10. VST Industries Ltd.
Customization available:
With the given market data, Research on Global Markets offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com, or connect with us here.
Chapter 1: Executive summary
Chapter 2: Socio-economic indicators
Chapter 3: Introduction
3.1. India tobacco market definition and structure
3.2. Top tobacco-producing states in India
Chapter 4: India tobacco market
4.1. Market overview
4.2. Tobacco harvest in India - volume-wise (FY 2016 - FY 2019e)
4.3. Flue-Cured Virginia (FCV) tobacco production in India (FY 2015 - FY 2018)
4.4. Average farm price of FCV tobacco in India (FY 2013 - FY 2017)
4.5. Tobacco market size and growth forecast - value-wise (based on tax revenue) (FY 2016-FY 2023e)
4.6. Per capita consumption of tobacco (FY 2017)
4.7. Per capita consumption of cigarette (FY 2017)
Chapter 5: India tobacco market segmentation
5.1. Based on harvest type (FY 2018)
5.1.1. Cigarette tobacco
5.1.2. Non-cigarette tobacco
5.2. Based on forms of consumption (2018)
5.2.1. Khaini
5.2.2. Beedi and cigarette
5.2.3. Others
5.3. Based on consumption-tax revenue (2017)
5.3.1. Legal cigarettes
5.3.2. Other tobacco products
5.4. Based on major players (2018)
5.4.1 ITC Ltd.
5.4.2 Kothari Products Ltd.
5.4.3 Godfrey Phillips India Ltd.
5.4.4 VST Industries Ltd.
5.4.5 Golden Tobacco Company Ltd.
5.4.6 NTC Industries Ltd.
Chapter 6: Trade analysis
6.1. Export of tobacco
6.1.1. Value-wise
6.1.2. Volume-wise
6.1.3. Country-wise
6.2. Import of tobacco
6.2.1. Value-wise
6.2.2. Volume-wise
6.2.3. Country-wise
Chapter 7: Key growth drivers of the market
Chapter 8: Key deterrents to the growth of the market
Chapter 9: Competitive landscape
9.1. Ashok and Company Pan Bahar Ltd.
9.1.1. Corporate information
9.1.2. Business description
9.1.3. Products and services
9.1.4. Key people
9.1.5. Financial snapshot (total income, net profit/loss)
9.1.6. Key ratios
9.1.7. Business segments, geographical segments
9.2. Godfrey Phillips India Ltd.
9.2.1. Corporate information
9.2.2. Business description
9.2.3. Products and services
9.2.4. Key people
9.2.5. Financial snapshot (total income, net profit/loss)
9.2.6. Key ratios
9.2.7. Business segments, geographical segments
9.3. Golden Tobacco Company Ltd.
9.3.1. Corporate information
9.3.2. Business description
9.3.3. Products and services
9.3.4. Key people
9.3.5. Financial snapshot (total income, net profit/loss)
9.3.6. Key ratios
9.3.7. Business segments, geographical segments
9.4. ITC Ltd.
9.4.1. Corporate information
9.4.2. Business description
9.4.3. Products and services
9.4.4. Key people
9.4.5. Financial snapshot (total income, net profit/loss)
9.4.6. Key ratios
9.4.7. Business segments, geographical segments
9.5. Kothari Products Ltd.
9.5.1. Corporate information
9.5.2. Business description
9.5.3. Products and services
9.5.4. Key people
9.5.5. Financial snapshot (total income, net profit/loss)
9.5.6. Key ratios
9.5.7. Business segments, geographical segments
9.6. M.R. Tobacco Pvt. Ltd.
9.6.1. Corporate information
9.6.2. Business description
9.6.3. Products and services
9.6.4. Key people
9.6.5. Financial snapshot (total income, net profit/loss)
9.6.6. Key ratios
9.6.7. Business segments, geographical segments
9.7. National Tobacco Company of India Ltd.
9.7.1 Corporate information
9.7.2 Business description
9.7.3 Products and services
9.7.4 Key people
9.7.5 Financial snapshot (total income, net profit/loss)
9.7.6 Key ratios
9.7.7 Business segments, geographical segments
9.8. Pataka Industries Pvt. Ltd.
9.8.1. Corporate information
9.8.2. Business description
9.8.3. Products and services
9.8.4. Key people
9.8.5. Financial snapshot (total income, net profit/loss)
9.8.6. Key ratios
9.8.7. Business segments, geographical segments
9.9. Sinnar Bidi Udyog Ltd.
9.9.1. Corporate information
9.9.2. Business description
9.9.3. Products and services
9.9.4. Key people
9.9.5. Financial snapshot (total income, net profit/loss)
9.9.6. Key ratios
9.9.7. Business segments, geographical segments
9.10. VST Industries Ltd.
9.10.1. Corporate information
9.10.2. Business description
9.10.3. Products and services
9.10.4. Key people
9.10.5. Financial snapshot (total income, net profit/loss)
9.10.6. Key ratios
9.10.7. Business segments, geographical segments
Appendix
1. Research methodology
2. About Research on Global Markets
The Tobacco Etch Virus Protease Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
Electroceuticals are gaining attention as a non-invasive neuromodulation method with the advantages of low risk and low cost, replacing risky and costly invasive brain stimulation. In particular, it is expected to be a safe and effective treatment for treatment-resistant patients who have adverse re...
As of 2022, the total market size of intraocular lenses in Korea is estimated to be approximately ***units (***USD) by manufacturers'/importers' initial selling unit and ***units (***USD) by medical institutions' purchase unit.
It is estimated that the relatively high production/import volume...
In this report, medical AI is defined as artificial intelligence used across the healthcare industry. AI-enabled medical devices are in particular referred to devices which assist healthcare providers in diagnosing, managing and/or predicting diseases through analyzing medical big data with artifici...
The new DRG is a mixed payment method in which the NHIS pays for medical expenses incurred during a single medical treatment, dividing the cost of procedures, drugs, and therapeutic materials into all-inclusive and non-inclusive fees.
Most medical services are comprehensively bundled together...
As of 2022, the total market size of the wound dressings in Korea is estimated to be approximately USD *** million, about an increase of ***% compared to the previous year. Reimbursement volume is estimated to be approximately USD *** million - around ***% of the entire market.
Afterwards, it...
As defined by the FDA, Digital Therapeutics (DTx) is a "Software as a Medical Device (SaMD) that provides evidence-based therapeutic interventions to non-patients for the purpose of preventing, managing, or treating a medical disorder or disease based on biometric information collected from general-...
In 2022, the total market size of dental implants in Korea is estimated to be approxiamately USD ***million at manufacturers/importers' initial selling prices (about *** units, including fixtures and upper parts) and USD *** million at medical institutions' purchase prices.
The dental implants...
Dermal fillers are classified by the MFDS as Class Ⅳ medical devices, with the product classification number B04230.01 (biomaterial graft/prosthesis) or B04230.02 (graft/prosthesis).
According to the , dermal fillers are non-rei...
In 2022, the total market size of anti-adhesion products in Korea is estimated to be approximately USD *** million (manufacturers/importers' initial selling prices) and USD *** million (medical institutions' purchase prices).
While some estimates put the market size at around USD *** million ...